# FDA Inspection 1256421 - Oklahoma Blood Institute Southwest - December 05, 2024

Source: https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-southwest/a67ece81-3bb8-4b72-8202-c3c2d056444b
Source feed: FDA_Inspections

> FDA Inspection 1256421 for Oklahoma Blood Institute Southwest on December 05, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256421
- Company Name: Oklahoma Blood Institute Southwest
- Inspection Date: 2024-12-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1256421 - 2024-12-05](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-southwest/1bfafdbb-f67a-47bd-be6d-0e7f6c7594f1)
- [FDA Inspection 1168571 - 2022-04-20](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-southwest/173e0d09-242b-4a9a-a33f-9ec9f7c7296c)
- [FDA Inspection 1168571 - 2022-04-20](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-southwest/8bb51ea4-12bf-4d60-a6eb-ee31d2ef6527)
- [FDA Inspection 1068887 - 2018-07-26](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-southwest/bb1ede5d-51e5-46da-a117-afc977896a1b)
- [FDA Inspection 975158 - 2016-03-16](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-southwest/3ba75498-c25a-42f5-87eb-070d236e737c)

Company: https://www.keypedia.com/companies/oklahoma-blood-institute-southwest/f221f7cc-687b-4376-bf8a-21aae84e2259

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d